|
|
||||||||
Gastrointestinal Imaging |
1 From the Department of Radiology, Städtisches Klinikum Karlsruhe, Moltkestrasse 90, D-76133 Karlsruhe, Germany (P.R.); the Department of Clinical Radiology, Westfälische Wilhelms-Universität Münster, Germany (N.J., M.F.); the Department of Radiology, University of Vienna, Austria (W.S.); the Department of Radiology, Universitair Ziekenhuis Antwerpen, Edegem, Belgium (F.D.); the Department of Radiology, Knappschafts-Krankenhaus Bochum-Langendreer-Universitätsklinik, Germany (C.M.); the Department of Diagnostic Radiology, Klinikum Grosshadern, Munich, Germany (N.H.); and the Department of Radiology, Division of Abdominal and Interventional Radiology, Massachusetts General Hospital, Boston (S.S.). Received August 12, 1999; revision requested September 28; revision received January 14, 2000; accepted January 27. Address correspondence to P.R. (e-mail: reimerp@uni-muenster.de).
PURPOSE: To determine the accuracy for detection and characterization of focal hepatic lesions of nonenhanced, superparamagnetic iron oxide (SPIO)-enhanced, or a combination of nonenhanced and SPIO-enhanced MR imaging and contrast-enhanced spiral computed tomography (CT).
MATERIALS AND METHODS: Spiral CT and T2-weighted SPIO-enhanced (ferucarbotran-enhanced) MR imaging were performed in 35 patients within 2 weeks before surgery for malignant hepatic lesions. Only malignant lesions with histopathologic proof were considered. A total of 875 images with and 800 images without focal lesions were presented to five readers, who were asked to assess the presence and characterization of lesions by using a five-point confidence scale. Receiver operating characteristic analysis was performed.
RESULTS: Nonenhanced and SPIO-enhanced images together and SPIO-enhanced images alone yielded the best performance for lesion detection. No differences were found among all imaging techniques with regard to lesion characterization (benign vs malignant). The combined approach resulted in larger area under the ROC curve (Az = 0.9062) and accuracy (85.3%) (P < 0.02), as compared with SPIO-enhanced MR imaging (Az = 0.8667; accuracy, 73.1%).
CONCLUSION: SPIO-enhanced T2-weighted MR imaging was more accurate than nonenhanced T1-weighted and T2-weighted MR imaging and contrast-enhanced spiral CT for the detection of focal hepatic lesions. The combined analysis of nonenhanced and SPIO-enhanced images was more accurate in the characterization of focal hepatic lesions than was review of SPIO-enhanced images alone.
Index terms: Contrast media Iron Liver neoplasms, 761.319, 761.323, 761.33 Liver neoplasms, MR, 761.121411, 761.121412, 761.12143 Magnetic resonance (MR), contrast media, 761.12143
This article has been cited by other articles:
![]() |
M. Bruegel, J. Gaa, S. Waldt, K. Woertler, K. Holzapfel, B. Kiefer, and E. J. Rummeny Diagnosis of Hepatic Metastasis: Comparison of Respiration-Triggered Diffusion-Weighted Echo-Planar MRI and Five T2-Weighted Turbo Spin-Echo Sequences Am. J. Roentgenol., November 1, 2008; 191(5): 1421 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, J. A. Guthrie, M. B. Sheridan, S. Boyes, J. T. Smith, D. Wilson, J. I. Wyatt, D. Treanor, and P. J. Robinson Sinusoidal Obstructive Syndrome Diagnosed With Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging in Patients With Chemotherapy-Treated Colorectal Liver Metastases J. Clin. Oncol., September 10, 2008; 26(26): 4304 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang Nano- and Microparticle-based Imaging of Cardiovascular Interventions: Overview Radiology, May 1, 2007; 243(2): 340 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kim, K. H. Lee, Y. H. Kim, S. W. Sung, S. Jheon, S.-k. Cho, and K. W. Lee Postoperative Imaging of Esophageal Cancer: What Chest Radiologists Need to Know RadioGraphics, March 1, 2007; 27(2): 409 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Kim, J. H. Kim, J. Y. Choi, S. H. Park, J.-J. Chung, K. W. Kim, and D. G. Mitchell Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. Am. J. Roentgenol., September 1, 2006; 187(3): W255 - W266. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schnorr, S. Wagner, C. Abramjuk, R. Drees, T. Schink, E. A. Schellenberger, H. Pilgrimm, B. Hamm, and M. Taupitz Focal Liver Lesions: SPIO-, Gadolinium-, and Ferucarbotran-enhanced Dynamic T1-weighted and Delayed T2-weighted MR Imaging in Rabbits Radiology, July 1, 2006; 240(1): 90 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kim, K. W. Kim, J. H. Byun, H. J. Won, Y. M. Shin, P. N. Kim, M.-S. Lee, and M.-G. Lee Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. Am. J. Roentgenol., April 1, 2006; 186(4): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Onishi, T. Murakami, T. Kim, M. Hori, R. Iannaccone, M. Kuwabara, H. Abe, S. Nakata, K. Osuga, K. Tomoda, et al. Hepatic Metastases: Detection with Multi-Detector Row CT, SPIO-enhanced MR Imaging, and Both Techniques Combined Radiology, April 1, 2006; 239(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. Kim, H. S. Kwak, C. S. Kim, G. H. Chung, Y. M. Han, and J. M. Lee Hepatocellular Carcinoma in Patients with Chronic Liver Disease: Comparison of SPIO-enhanced MR Imaging and 16-Detector Row CT Radiology, December 21, 2005; (2005) 2381042193. [Abstract] [Full Text] |
||||
![]() |
A. M. Lutz, J. K. Willmann, K. Goepfert, B. Marincek, and D. Weishaupt Hepatocellular Carcinoma in Cirrhosis: Enhancement Patterns at Dynamic Gadolinium- and Superparamagnetic Iron Oxide-enhanced T1-weighted MR Imaging Radiology, November 1, 2005; 237(2): 520 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, P. J. Robinson, J. A. Guthrie, S. Downing, D. Wilson, J. P. A. Lodge, K. R. Prasad, G. J. Toogood, and J. I. Wyatt Liver Metastases in Candidates for Hepatic Resection: Comparison of Helical CT and Gadolinium- and SPIO-enhanced MR Imaging Radiology, October 1, 2005; 237(1): 170 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, D. Choi, S. H. Kim, J. H. Lim, W. J. Lee, M. J. Kim, H. K. Lim, and S. J. Lee Ferucarbotran-Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma Am. J. Roentgenol., April 1, 2005; 184(4): 1069 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazumdar Group Sequential Design for Comparative Diagnostic Accuracy Studies: Implications and Guidelines for Practitioners Med Decis Making, October 1, 2004; 24(5): 525 - 533. [Abstract] [PDF] |
||||
![]() |
K. W. Kim, A. Y. Kim, T. K. Kim, S. H. Park, H. J. Kim, Y. K. Lee, M.-S. Park, H. K. Ha, P. N. Kim, J. C. Kim, et al. Small (l.e. 2cm) Hepatic Lesions in Colorectal Cancer Patients: Detection and Characterization on Mangafodipir Trisodium-Enhanced MRI Am. J. Roentgenol., May 1, 2004; 182(5): 1233 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsuo, M. Kanematsu, K. Itoh, T. Murakami, Y. Maetani, H. Kondo, S. Goshima, N. Kako, H. Hoshi, J. Konishi, et al. Detection of Malignant Hepatic Tumors with Ferumoxides-Enhanced MRI: Comparison of Five Gradient-Recalled Echo Sequences with Different TEs Am. J. Roentgenol., January 1, 2004; 182(1): 235 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumano, T. Murakami, T. Kim, M. Hori, A. Okada, T. Sugiura, Y. Noguchi, S. Kawata, K. Tomoda, and H. Nakamura Using Superparamagnetic Iron Oxide-Enhanced MRI to Differentiate Metastatic Hepatic Tumors and Nonsolid Benign Lesions Am. J. Roentgenol., November 1, 2003; 181(5): 1335 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Kim, J. H. Kim, J.-J. Chung, M. S. Park, J. S. Lim, and Y. T. Oh Focal Hepatic Lesions: Detection and Characterization with Combination Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging Radiology, September 1, 2003; 228(3): 719 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ward, J. A. Guthrie, D. Wilson, P. Arnold, J. P. Lodge, G. J. Toogood, J. I. Wyatt, and P. J. Robinson Colorectal Hepatic Metastases: Detection with SPIO-enhanced Breath-hold MR Imaging—Comparison of Optimized Sequences Radiology, September 1, 2003; 228(3): 709 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bluemke, T. M. Weber, D. Rubin, E. E. de Lange, R. Semelka, R. D. Redvanly, J. Chezmar, E. Outwater, R. Carlos, S. Saini, et al. Hepatic MR Imaging with Ferumoxides: Multicenter Study of Safety and Effectiveness of Direct Injection Protocol Radiology, August 1, 2003; 228(2): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Frate, C. Zuiani, V. Londero, G. Como, M. Bazzocchi, K. Mortele, and P. R. Ros Comparing Levovist-Enhanced Pulse Inversion Harmonic Imaging and Ferumoxides-Enhanced MR Imaging of Hepatic Metastases Am. J. Roentgenol., May 1, 2003; 180(5): 1339 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mori, J. Scheidler, T. Helmberger, N. Holzknecht, R. Schauer, C. A. Schirren, I. Bittmann, M. Dugas, and M. Reiser Detection of Malignant Hepatic Lesions Before Orthotopic Liver Transplantation: Accuracy of Ferumoxides-Enhanced MR Imaging Am. J. Roentgenol., October 1, 2002; 179(4): 1045 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Arbab, T. Ichikawa, H. Sou, T. Araki, H. Nakajima, K. Ishigame, T. Yoshikawa, and H. Kumagai Ferumoxides-enhanced Double-Echo T2-weighted MR Imaging in Differentiating Metastases from Nonsolid Benign Lesions of the Liver Radiology, October 1, 2002; 225(1): 151 - 158. [Abstract] [Full Text] [PDF] |
||||